Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Authors not listed

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · 2022

Abstract

Treatment of age-related macular degeneration using retinal stem and progenitor cells

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-09 MST

Cite this

APA
Anonymous. (2022). Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells. <em>Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus</em>. https://clinicaltrials.gov/study/NCT05187104
Vancouver
Anonymous. Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells. Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus. 2022.
BibTeX
@misc{anon2022Treatm, title = {Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells}, author = {Anonymous}, journal = {Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus}, year = {2022}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings